The first Sarepta Therapeutics trade was made in Q3 2015. Since then Paul Tudor Jones II bought shares eleven more times and sold shares on twelve occasions. The investor sold all their shares in Q1 2024 and doesn't own any shares in Sarepta Therapeutics anymore.
Related Stocks: MRTX , AMGN , INCY , TVTX , EXEL , NBIX , HZNP , ILMN , IDYA , LEGN , ZGNX , RCKT , REGN , ALNY , BIIB , SGEN , IONS , QURE , UTHR , XLRN , P...
Basel, 24 September 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced data from across its growing neuromuscular portfolio at the World Muscle Societ...
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) ...